General Information of Drug Off-Target (DOT) (ID: OTVDSNLH)

DOT Name Glutathione S-transferase omega-2 (GSTO2)
Synonyms GSTO-2; EC 2.5.1.18; Glutathione S-transferase omega 2-2; GSTO 2-2; Glutathione-dependent dehydroascorbate reductase; EC 1.8.5.1; Monomethylarsonic acid reductase; MMA(V) reductase; EC 1.20.4.2
Gene Name GSTO2
UniProt ID
GSTO2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
3Q18; 3Q19; 3QAG
EC Number
1.20.4.2; 1.8.5.1; 2.5.1.18
Pfam ID
PF13417
Sequence
MSGDATRTLGKGSQPPGPVPEGLIRIYSMRFCPYSHRTRLVLKAKDIRHEVVNINLRNKP
EWYYTKHPFGHIPVLETSQCQLIYESVIACEYLDDAYPGRKLFPYDPYERARQKMLLELF
CKVPHLTKECLVALRCGRECTNLKAALRQEFSNLEEILEYQNTTFFGGTCISMIDYLLWP
WFERLDVYGILDCVSHTPALRLWISAMKWDPTVCALLMDKSIFQGFLNLYFQNNPNAFDF
GLC
Function
Exhibits glutathione-dependent thiol transferase activity. Has high dehydroascorbate reductase activity and may contribute to the recycling of ascorbic acid. Participates in the biotransformation of inorganic arsenic and reduces monomethylarsonic acid (MMA).
Tissue Specificity Expressed in a range of tissues, including the liver, kidney, skeletal muscle and prostate. Strongest expression in the testis.
KEGG Pathway
Glutathione metabolism (hsa00480 )
Metabolism of xenobiotics by cytochrome P450 (hsa00980 )
Drug metabolism - cytochrome P450 (hsa00982 )
Drug metabolism - other enzymes (hsa00983 )
Metabolic pathways (hsa01100 )
Platinum drug resistance (hsa01524 )
Pathways in cancer (hsa05200 )
Chemical carcinogenesis - D. adducts (hsa05204 )
Chemical carcinogenesis - receptor activation (hsa05207 )
Chemical carcinogenesis - reactive oxygen species (hsa05208 )
Hepatocellular carcinoma (hsa05225 )
Fluid shear stress and atherosclerosis (hsa05418 )
Reactome Pathway
Vitamin C (ascorbate) metabolism (R-HSA-196836 )
Glutathione conjugation (R-HSA-156590 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Glutathione S-transferase omega-2 (GSTO2) increases the response to substance of Arsenic. [12]
------------------------------------------------------------------------------------
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Glutathione S-transferase omega-2 (GSTO2). [1]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Glutathione S-transferase omega-2 (GSTO2). [2]
Cisplatin DMRHGI9 Approved Cisplatin affects the expression of Glutathione S-transferase omega-2 (GSTO2). [3]
Estradiol DMUNTE3 Approved Estradiol affects the expression of Glutathione S-transferase omega-2 (GSTO2). [4]
Quercetin DM3NC4M Approved Quercetin affects the expression of Glutathione S-transferase omega-2 (GSTO2). [5]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Glutathione S-transferase omega-2 (GSTO2). [6]
Decitabine DMQL8XJ Approved Decitabine affects the expression of Glutathione S-transferase omega-2 (GSTO2). [3]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Glutathione S-transferase omega-2 (GSTO2). [7]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Glutathione S-transferase omega-2 (GSTO2). [8]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of Glutathione S-transferase omega-2 (GSTO2). [9]
MG-132 DMKA2YS Preclinical MG-132 increases the expression of Glutathione S-transferase omega-2 (GSTO2). [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Glutathione S-transferase omega-2 (GSTO2). [10]
------------------------------------------------------------------------------------

References

1 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
2 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
3 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
4 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
5 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
6 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
7 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
8 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
9 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
10 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
11 Differential effects of arsenic species on Nrf2 and Bach1 nuclear localization in cultured hepatocytes. Toxicol Appl Pharmacol. 2021 Feb 15;413:115404. doi: 10.1016/j.taap.2021.115404. Epub 2021 Jan 9.
12 Association between arsenic metabolism gene polymorphisms and arsenic-induced skin lesions in individuals exposed to high-dose inorganic arsenic in northwest China. Sci Rep. 2018 Jan 11;8(1):413. doi: 10.1038/s41598-017-18925-3.